KW	category	node_weight	occurrence	btw_cnt	cls_cnt	strength	qscore	Knode	ranking
abdominal pain/chemically induced	MESH	0.010752688172043	1	253.416666666667	0.387817032329816	1.01885820526487	0.271312860555912	-10.7719088068107	252
abdominal pain/etiology	MESH	0.0104166666666666	1	0	0.348201333855161	1.48155513799669	0.226909853738127	5.89788604221745	83
ACAD8	GENE	0.021505376344086	2	767.138888888889	0.349754274456192	1.86790670965226	0.477390594953674	2.54084506316395	106
adenocarcinoma of lung/drug therapy	MESH	0.010752688172043	1	0	0.306696790386986	0.509429102632434	0.0756366179127091	0.281950985650718	125
adrenal cortex hormones/pharmacology	MESH	0.0106382978723404	1	0	0.384230058090875	0.180753594022051	0.0189091544781773	-9.26322026415737	216
adrenal cortex hormones/therapeutic use	MESH	0.032258064516129	3	4729.64285714286	0.476356351248852	4.00980142635133	0.947278713361692	-9.97250780247218	244
adrenal gland diseases/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	2
adrenal insufficiency/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	14
AHR	GENE	0.010752688172043	1	1606.30952380952	0.423259351911908	0.679238803509912	0.20800069925995	-8.4021511995583	197
angiogenesis inhibitors/therapeutic use	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	7
anti-bacterial agents	MESH	0.0106382978723404	1	0	0.384230058090875	0.180753594022051	0.0189091544781773	-9.26322026415737	217
anti-bacterial agents/adverse effects	MESH	0.010752688172043	1	0	0.384027234545669	0.679238803509912	0.101421828564769	-9.75400787925831	240
anti-bacterial agents/pharmacology	MESH	0.010752688172043	1	650	0.407595842083464	1.01885820526487	0.309466231571587	-4.18153184793204	150
antibodies monoclonal humanized	MESH	0.010752688172043	1	0	0.385146660279719	0.520372995777007	0.0825126740865917	-9.62880491952643	236
antibodies monoclonal humanized/administration & dosage	MESH	0.010752688172043	1	365.5	0.326776191238732	0.84904850438739	0.221796515354583	23.3704866189081	42
antibodies monoclonal humanized/adverse effects	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	3
antibodies monoclonal humanized/therapeutic use	MESH	0.010752688172043	1	0	0.292015372107767	0.339619401754956	0.0446943651302372	-6.02062031580299	173
antibodies monoclonal/adverse effects	MESH	0.010752688172043	1	64.6527777777778	0.415351597205809	1.01885820526487	0.224680962647864	-6.38644759644936	179
antineoplastic agents immunological/adverse effects	MESH	0.075268817204301	7	6469.4	0.557806730928718	4.6042922007844	0.965940213274285	-11.3009066333499	255
antineoplastic agents immunological/therapeutic use	MESH	0.032258064516129	3	0	0.295293593289512	0.84904850438739	0.128926053260299	-7.58309754436222	184
antineoplastic agents/adverse effects	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	158
APC	GENE	0.021505376344086	2	3728.5	0.285418105513948	3.98136871449464	0.936163393741623	23.4997659536725	40
apoptosis/drug effects	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	163
ARG1	GENE	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	39
arthritis/chemically induced	MESH	0.010752688172043	1	254.104166666667	0.269595641201253	1.01885820526487	0.276965211817493	25.1402337506909	27
axitinib/administration & dosage	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	10
azoxymethane/adverse effects	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	35
b7-h1 antigen/antagonists & inhibitors	MESH	0.032258064516129	3	961.5	0.409852627462106	1.91650389239936	0.496824194394266	-1.40653727204219	133
b7-h1 antigen/genetics	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	49
b7-h1 antigen/metabolism	MESH	0.010752688172043	1	0	0.320033043605423	0.84904850438739	0.128926053260299	-2.14629212073704	138
beclomethasone/adverse effects	MESH	0.010752688172043	1	0	0.397601123065594	0.690182696654485	0.10485985665171	-8.16602614215962	187
bevacizumab/administration & dosage	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	6
biological products/therapeutic use	MESH	0.010752688172043	1	0	0.389741541246979	0.509429102632434	0.0756366179127091	-8.70290607522753	202
biomarkers/analysis	MESH	0.010752688172043	1	245.061507936508	0.419709323343332	3.75442840342281	0.687430802400792	-6.89898986084954	182
biomarkers/metabolism	MESH	0.010752688172043	1	0	0.306696790386986	0.509429102632434	0.0756366179127091	0.281950985650718	124
BTLA	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	92
butyrates/metabolism	MESH	0.010752688172043	1	0	0.382625086511798	0.169809700877478	0.0120330983042946	-9.21902478498441	210
carcinoma non-small-cell lung	MESH	0.010752688172043	1	0	0.383093534304753	0.339619401754956	0.0446943651302372	-9.45914204506677	226
carcinoma non-small-cell lung/complications	MESH	0.010752688172043	1	635.5	0.353051185470503	1.18866790614235	0.342928733756774	8.08316227145964	72
carcinoma non-small-cell lung/drug therapy	MESH	0.021505376344086	2	1935.33333333333	0.427492471470702	0.520372995777007	0.170619427772274	2.70071084246585	105
carcinoma renal cell/drug therapy	MESH	0.021505376344086	2	314.25	0.341735580963824	2.96251050922977	0.692267350387507	22.1679805913258	45
CD274	GENE	0.161290322580645	15	421	0.4223144043928	2.64177930957608	0.657391760386924	0.303985768301936	112
CD28	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	91
CD4	GENE	0.021505376344086	2	414.75	0.323342891450211	2.20015149229959	0.576190198706369	11.2356015547114	69
CD68	GENE	0.021505376344086	2	414.75	0.323342891450211	2.20015149229959	0.576190198706369	11.2356015547114	68
cd8-positive t-lymphocytes	MESH	0.010752688172043	1	0	0.383093534304753	0.339619401754956	0.0446943651302372	-9.45914204506677	227
cd8-positive t-lymphocytes/cytology	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	123
cd8-positive t-lymphocytes/drug effects	MESH	0.021505376344086	2	39	0.303452634543438	3.1897472921677	0.527460520948663	7.46639244472006	78
cd8-positive t-lymphocytes/immunology	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	21
CD8A	GENE	0.053763440860215	5	0	0.290608992601104	2.51850152318235	0.345521822737603	12.7131068313598	62
cell line tumor	MESH	0.021505376344086	2	691.5	0.254352083125457	3.4719396118622	0.795218810092652	26.1193316262385	16
chemical and drug induced liver injury/diagnosis	MESH	0.010752688172043	1	0	0.382625086511798	0.169809700877478	0.0120330983042946	-9.21902478498441	211
chemokines/metabolism	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	113
CHI3L1	GENE	0.010752688172043	1	254.104166666667	0.269595641201253	1.01885820526487	0.276965211817493	25.1402337506909	28
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	159
clostridium infections/chemically induced	MESH	0.010752688172043	1	0	0.384027234545669	0.679238803509912	0.101421828564769	-9.75400787925831	238
colitis	MESH	0.043010752688172	4	2630.5	0.491025873237248	2.50167858934444	0.722568614882583	-8.95898298093237	205
colitis collagenous/drug therapy	MESH	0.010752688172043	1	0	0.295492926557018	0.509429102632434	0.0756366179127091	-0.287950486835561	130
colitis microscopic/chemically induced	MESH	0.021505376344086	2	134.5	0.423595557934862	0.585174696945077	0.136661616455917	-9.7819444266504	242
colitis microscopic/diagnosis	MESH	0.0104166666666666	1	0	0.339783420878406	1.11116635349752	0.170182390303595	0.74449344589133	110
colitis ulcerative	MESH	0.010752688172043	1	0	0.382627285313004	0.169809700877478	0.0120330983042946	-9.23348897180159	213
colitis ulcerative/chemically induced	MESH	0.010752688172043	1	0	0.386172604275427	1.18866790614235	0.189091544781773	-9.5590888834226	232
colitis ulcerative/drug therapy	MESH	0.021505376344086	2	1011.91666666667	0.383915485376007	3.41453581169448	0.831609463317988	2.79016169837967	104
colitis ulcerative/immunology	MESH	0.021505376344086	2	39	0.303452634543438	3.1897472921677	0.527460520948663	7.46639244472006	77
colitis ulcerative/physiopathology	MESH	0.010752688172043	1	0	0.237872811566293	0.339619401754956	0.0446943651302372	-6.30211920201152	176
colitis/chemically induced	MESH	0.741935483870968	69	29993.5	0.55975374324538	4.9988281199572	0.988549618320611	-11.701213003466	260
colitis/diagnosis	MESH	0.021505376344086	2	60	0.336580930712443	1.18866790614235	0.245178019928909	-4.46478623630931	151
colitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	7
colitis/drug therapy	MESH	0.032258064516129	3	793	0.339795523037469	2.88676491491713	0.744012586679098	2.07838633724124	107
colitis/epidemiology	MESH	0.010752688172043	1	0	0.361753094477693	0.509429102632434	0.0756366179127091	-2.91083532073334	142
colitis/etiology	MESH	0.021505376344086	2	2738	0.343109083700587	2.20752611140721	0.70009032107686	11.4568149553086	67
colitis/therapy	MESH	0.010752688172043	1	0	0.382955507975302	0.339619401754956	0.0446943651302372	-9.34331872876784	223
colon/chemistry	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	156
colon/diagnostic imaging	MESH	0.010752688172043	1	0	0.314878494180074	1.35847760701982	0.211438727346891	-5.940139017898	167
colon/drug effects	MESH	0.032258064516129	3	897.788888888889	0.319948669068241	3.57756602698856	0.837931938698211	8.7008663038827	70
colon/immunology	MESH	0.021505376344086	2	0.5	0.422934920110299	0.754984397822555	0.107482081463784	-10.0555545501316	245
colonic neoplasms/drug therapy	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	34
colorectal neoplasms/drug therapy	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	47
crohn disease/drug therapy	MESH	0.010752688172043	1	0	0.396223484233421	0.339619401754956	0.0446943651302372	-9.32990168187502	222
crohn disease/immunology	MESH	0.010752688172043	1	0	0.2711591226367	1.35847760701982	0.211438727346891	11.658568211891	66
crohn disease/physiopathology	MESH	0.010752688172043	1	0	0.237872811566293	0.339619401754956	0.0446943651302372	-6.30211920201152	177
CRP	GENE	0.010752688172043	1	635.5	0.353051185470503	1.18866790614235	0.342928733756774	8.08316227145964	74
CSF2	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	87
ctla-4 antigen/antagonists & inhibitors	MESH	0.032258064516129	3	1248.37777777778	0.452394821570383	2.73840398522122	0.75636617912709	-6.2373701528089	175
ctla-4 antigen/immunology	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	117
CTLA4	GENE	0.129032258064516	12	1133	0.422322078473377	4.02804116291651	0.87267641745819	0.26653658338348	127
CXCL10	GENE	0.010752688172043	1	0	0.35571089629029	1.01885820526487	0.166744362216654	-8.36285698528234	195
CXCL8	GENE	0.010752688172043	1	254.104166666667	0.269595641201253	1.01885820526487	0.276965211817493	25.1402337506909	26
CXCL9	GENE	0.010752688172043	1	0	0.35571089629029	1.01885820526487	0.166744362216654	-8.36285698528234	196
cytomegalovirus infections/complications	MESH	0.010752688172043	1	0	0.382627285313004	0.169809700877478	0.0120330983042946	-9.23348897180159	212
cytomegalovirus infections/diagnosis	MESH	0.010752688172043	1	0	0.3817165234473	0.169809700877478	0.0120330983042946	-8.90392542244494	204
cytotoxicity immunologic	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	19
dermatitis	MESH	0.010752688172043	1	0	0.35571089629029	1.01885820526487	0.166744362216654	-8.36285698528234	193
dextran sulfate/adverse effects	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	30
diabetes mellitus type 1/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	4
diarrhea	MESH	0.021505376344086	2	0	0.435986676474871	1.34015909476763	0.190810558825243	-10.1281717054347	246
diarrhea/chemically induced	MESH	0.150537634408602	14	4744.7619047619	0.543238587423898	2.76301147172498	0.824194394266068	-11.2693302704653	254
diarrhea/diagnosis	MESH	0.0104166666666666	1	0	0.339783420878406	1.11116635349752	0.170182390303595	0.74449344589133	109
diarrhea/etiology	MESH	0.0104166666666666	1	0	0.348201333855161	1.48155513799669	0.226909853738127	5.89788604221745	80
diarrhea/therapy	MESH	0.010752688172043	1	52.75	0.392248922991031	0.509429102632434	0.0974302196841676	-8.57928683323799	199
disease progression	MESH	0.010752688172043	1	253.416666666667	0.387817032329816	1.01885820526487	0.271312860555912	-10.7719088068107	250
disease susceptibility	MESH	0.010752688172043	1	63.3333333333333	0.389296757576958	0.509429102632434	0.0993531845463551	-10.7173723121302	249
dose-response relationship drug	MESH	0.021505376344086	2	1917.25	0.378378888056422	2.50041334326156	0.70446069576365	12.7142440404933	61
drug resistance/immunology	MESH	0.010752688172043	1	0	0.314878494180074	1.35847760701982	0.211438727346891	-5.940139017898	170
drug synergism	MESH	0.021505376344086	2	691.5	0.254352083125457	3.4719396118622	0.795218810092652	26.1193316262385	17
drug-related side effects and adverse reactions	MESH	0.021505376344086	2	2553.1	0.405568897003887	1.5282873078973	0.485767146436688	-4.67261023475787	152
drug-related side effects and adverse reactions/diagnosis	MESH	0.010752688172043	1	0	0.393326461906188	0.524813794004542	0.0876697162170037	-6.92649263138506	183
drug-related side effects and adverse reactions/prevention & control	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	23
drugs investigational/administration & dosage	MESH	0.010752688172043	1	365.5	0.326776191238732	0.84904850438739	0.221796515354583	23.3704866189081	41
dysbiosis/etiology	MESH	0.010752688172043	1	650	0.407595842083464	1.01885820526487	0.309466231571587	-4.18153184793204	147
encephalitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	9
endometrial neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.385146660279719	0.520372995777007	0.0825126740865917	-9.62880491952643	234
enterocolitis/chemically induced	MESH	0.021505376344086	2	516.833333333333	0.295849359066141	1.18866790614235	0.333313909445836	-8.03538841526535	186
escherichia coli infections/drug therapy	MESH	0.010752688172043	1	0	0.384027234545669	0.679238803509912	0.101421828564769	-9.75400787925831	241
esophagitis	MESH	0.010752688172043	1	0	0.383093534304753	0.339619401754956	0.0446943651302372	-9.45914204506677	225
exanthema/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	3
fatigue/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	11
feces	MESH	0.010752688172043	1	17.5	0.409016402693232	0.509429102632434	0.0794825476370841	-2.95568559549793	143
feces/chemistry	MESH	0.010752688172043	1	1391.85317460317	0.442542413517572	2.95747457747802	0.828652176446594	-2.38714682668787	141
gastritis/chemically induced	MESH	0.0106382978723404	1	0	0.384230058090875	0.180753594022051	0.0189091544781773	-9.26322026415737	218
gastritis/complications	MESH	0.010752688172043	1	253.416666666667	0.387817032329816	1.01885820526487	0.271312860555912	-10.7719088068107	253
gastrointestinal hemorrhage/etiology	MESH	0.0104166666666666	1	0	0.348201333855161	1.48155513799669	0.226909853738127	5.89788604221745	79
gastrointestinal neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	84
gastrointestinal tract/metabolism	MESH	0.010752688172043	1	0	0.320033043605423	0.84904850438739	0.128926053260299	-2.14629212073704	139
gene expression regulation neoplastic	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	54
gene expression regulation/genetics	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	118
gentian violet	MESH	0.010752688172043	1	0	1.20454310422196	0.169809700877478	1	0	1
glucocorticoids	MESH	0.010752688172043	1	254.104166666667	0.269595641201253	1.01885820526487	0.276965211817493	25.1402337506909	29
glucocorticoids/administration & dosage	MESH	0.0104166666666666	1	0	0.348201333855161	1.48155513799669	0.226909853738127	5.89788604221745	81
glucocorticoids/pharmacology	MESH	0.010752688172043	1	0	0.314878494180074	1.35847760701982	0.211438727346891	-5.940139017898	168
glucocorticoids/therapeutic use	MESH	0.010752688172043	1	253.416666666667	0.387817032329816	1.01885820526487	0.271312860555912	-10.7719088068107	251
glycoproteins/metabolism	MESH	0.010752688172043	1	0	0.306696790386986	0.509429102632434	0.0756366179127091	0.281950985650718	126
graft vs host disease/immunology	MESH	0.010752688172043	1	0	0.2711591226367	1.35847760701982	0.211438727346891	11.658568211891	64
growth inhibitors/therapeutic use	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	20
hashimoto disease/chemically induced	MESH	0.010752688172043	1	0	0.386172604275427	1.18866790614235	0.189091544781773	-9.5590888834226	231
HAVCR2	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	90
hepatitis autoimmune/etiology	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	8
hepatitis/diagnosis	MESH	0.010752688172043	1	0	0.382625086511798	0.169809700877478	0.0120330983042946	-9.21902478498441	209
hepatitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	5
host microbial interactions/drug effects	MESH	0.010752688172043	1	650	0.407595842083464	1.01885820526487	0.309466231571587	-4.18153184793204	149
ht29 cells	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	57
hypophysitis/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	9
IL15	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	89
IL17A	GENE	0.021505376344086	2	583	0.233491302505434	2.54714551316217	0.654682128081114	23.1311291098785	44
IL17C	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	85
IL21	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	93
IL22	GENE	0.021505376344086	2	3128.16666666667	0.352793026566851	2.55808940630674	0.789814113396655	1.21976955343575	108
IL4	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	86
IL6	GENE	0.021505376344086	2	1424.08333333333	0.302280324168227	2.72789910718422	0.762499271604219	12.1151376128045	63
immune checkpoint inhibitors	MESH	0.32258064516129	30	17896.5	0.559753743245286	6.9071251487983	0.99236641221374	-11.7226111989345	261
immune checkpoint inhibitors/administration & dosage	MESH	0.043010752688172	4	3646.5	0.319966180499583	1.60403290220994	0.499271604218868	21.9224790522102	46
immune checkpoint inhibitors/adverse effects	MESH	0.56989247311828	53	19866.875	0.55975374324538	4.71176166376074	0.980974302196842	-11.6859547930912	259
immune checkpoint inhibitors/pharmacology	MESH	0.043010752688172	4	1597.31706349206	0.365484274892216	2.55808940630674	0.75520074587728	-1.83930208762254	136
immune checkpoint inhibitors/therapeutic use	MESH	0.021505376344086	2	750	0.271813991067622	3.76600470626444	0.818658586329468	33.3028526533971	1
immune system diseases/drug therapy	MESH	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	88
immunocompromised host	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	6
immunologic factors	MESH	0.021505376344086	2	0	0.422537306534222	0.585174696945077	0.091107744303945	-9.86546464854555	243
immunologic memory/drug effects	MESH	0.010752688172043	1	338.333333333333	0.351377059599126	1.35847760701982	0.358370724316765	-0.672544327269874	132
immunosuppressive agents/pharmacology	MESH	0.010752688172043	1	0	0.314878494180074	1.35847760701982	0.211438727346891	-5.940139017898	171
immunosuppressive agents/therapeutic use	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	1
inflammation	MESH	0.010752688172043	1	0	1.20454310422196	0.169809700877478	1	0	2
inflammation/drug therapy	MESH	0.021505376344086	2	2006.72619047619	0.35467253974558	2.37733581228469	0.705990326904027	-5.56211210070233	166
inflammatory bowel diseases	MESH	0.021505376344086	2	855.714285714286	0.395823712586891	1.5282873078973	0.452333780082746	-5.22044773231021	153
inflammatory bowel diseases/complications	MESH	0.021505376344086	2	4	0.357736779063444	0.773808253414722	0.111051220791329	3.19517208928216	100
inflammatory bowel diseases/drug therapy	MESH	0.032258064516129	3	1947.5	0.403632056678531	1.43422320133247	0.453280694598217	8.24476968705212	71
infliximab/administration & dosage	MESH	0.010752688172043	1	635.5	0.353051185470503	1.18866790614235	0.342928733756774	8.08316227145964	75
infliximab/adverse effects	MESH	0.043010752688172	4	782.5	0.384519466570161	2.63383500061939	0.717600955655265	-8.58501577322999	201
interferon-gamma/metabolism	MESH	0.010752688172043	1	338.333333333333	0.351377059599126	1.35847760701982	0.358370724316765	-0.672544327269874	131
interleukin-12/antagonists & inhibitors	MESH	0.010752688172043	1	0	0.291937745661787	0.509429102632434	0.0756366179127091	2.79283374408792	103
interleukin-17/genetics	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	48
interleukin-23/antagonists & inhibitors	MESH	0.010752688172043	1	0	0.291937745661787	0.509429102632434	0.0756366179127091	2.79283374408792	101
intestinal mucosa/chemistry	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	154
intestinal mucosa/diagnostic imaging	MESH	0.010752688172043	1	0	0.314878494180074	1.35847760701982	0.211438727346891	-5.940139017898	172
intestinal mucosa/immunology	MESH	0.010752688172043	1	0	0.382953305400168	0.339619401754956	0.0446943651302372	-9.31891744420854	220
ipilimumab/adverse effects	MESH	0.0967741935483871	9	1.5	0.559480730313446	2.32842038694957	0.342637375444321	-11.5626426946475	257
ipilimumab/therapeutic use	MESH	0.032258064516129	3	555.25	0.375434110009794	3.54768520617485	0.755084202552299	19.8868795986877	59
leukemia lymphocytic chronic b-cell/drug therapy	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	165
leukocyte l1 antigen complex/analysis	MESH	0.010752688172043	1	1391.85317460317	0.442542413517572	2.95747457747802	0.828652176446594	-2.38714682668787	140
LIF	GENE	0.010752688172043	1	0	0.285487422986818	2.03771641052974	0.326612668259425	5.83355073930571	94
ligands	MESH	0.010752688172043	1	0	0.357857775196501	0.524813794004542	0.0876697162170037	-3.3294077904013	144
LTF	GENE	0.010752688172043	1	0	0.397445890233225	0.690182696654485	0.10485985665171	-9.70434006202994	237
lung neoplasms	MESH	0.010752688172043	1	148	0.389525148187781	0.339619401754956	0.0674203135015442	-9.24678416636977	214
lung neoplasms/drug therapy	MESH	0.021505376344086	2	0	0.383068256707287	0.339619401754956	0.0446943651302372	-9.27091470679864	219
lymphocytes tumor-infiltrating/immunology	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	18
lymphocytes tumor-infiltrating/metabolism	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	50
lymphocytes/drug effects	MESH	0.010752688172043	1	64.6527777777778	0.415351597205809	1.01885820526487	0.224680962647864	-6.38644759644936	178
lymphocytosis/chemically induced	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	161
lymphoma non-hodgkin/drug therapy	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	157
macrophages/drug effects	MESH	0.010752688172043	1	0	0.2711591226367	1.35847760701982	0.211438727346891	11.658568211891	65
melanoma/complications	MESH	0.032258064516129	3	756.355555555556	0.368686879359797	2.21847000455179	0.633063341297127	0.165156202622681	128
melanoma/drug therapy	MESH	0.053763440860215	5	1190.6	0.409184232359011	2.7743822961001	0.760008158032749	-8.86561222286367	203
melanoma/genetics	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	115
melanoma/immunology	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	4
mesalamine/pharmacology	MESH	0.010752688172043	1	66.4944444444445	0.308037810226258	0.84904850438739	0.177000174814987	4.59422445269527	97
metabolome/drug effects	MESH	0.010752688172043	1	650	0.407595842083464	1.01885820526487	0.309466231571587	-4.18153184793204	148
micrornas/genetics	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	52
MIR15B	GENE	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	53
MTOR	GENE	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	25
mucositis/chemically induced	MESH	0.010752688172043	1	0	0.314878494180074	1.35847760701982	0.211438727346891	-5.940139017898	169
multigene family	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	121
myasthenia gravis/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	15
myasthenia gravis/diagnosis	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	5
mycophenolic acid	MESH	0.0106382978723404	1	0	0.384230058090875	0.180753594022051	0.0189091544781773	-9.26322026415737	215
myeloid cells/cytology	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	122
myeloid-derived suppressor cells/metabolism	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	32
myocarditis/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	12
myocarditis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	6
neoplasm recurrence local/drug therapy	MESH	0.010752688172043	1	0	0.385146660279719	0.520372995777007	0.0825126740865917	-9.62880491952643	235
neoplasms	MESH	0.043010752688172	4	92	0.43993039460554	1.43422320133247	0.32049414369792	-11.3888667732443	256
neoplasms/complications	MESH	0.032258064516129	3	270	0.335962950505551	1.35847760701982	0.352995163452013	5.33772340256426	95
neoplasms/diagnosis	MESH	0.010752688172043	1	365.5	0.326776191238732	0.84904850438739	0.221796515354583	23.3704866189081	43
neoplasms/diagnostic imaging	MESH	0.021505376344086	2	0	1.20454310422196	1.69809700877478	1	0	10
neoplasms/drug therapy	MESH	0.129032258064516	12	13334.3392857143	0.559749037515871	6.73370479221127	0.984776528174349	-11.7285969051242	262
neoplasms/therapy	MESH	0.010752688172043	1	52.75	0.392248922991031	0.509429102632434	0.0974302196841676	-8.57928683323799	200
nephritis/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	13
neutrophils/drug effects	MESH	0.010752688172043	1	64.6527777777778	0.415351597205809	1.01885820526487	0.224680962647864	-6.38644759644936	180
nivolumab/adverse effects	MESH	0.129032258064516	12	4175.83333333333	0.559699778895577	5.20704312164214	0.962065147718664	-11.5936777831935	258
nivolumab/therapeutic use	MESH	0.021505376344086	2	764	0.275931796909881	2.88676491491713	0.734222947380689	30.5441455092955	2
NRF1	GENE	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	55
oropharyngeal neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.382602069204931	0.169809700877478	0.0120330983042946	-9.07313328107801	207
paclitaxel/therapeutic use	MESH	0.010752688172043	1	0	0.386172604275427	1.18866790614235	0.189091544781773	-9.5590888834226	233
pancreatitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	8
PARP1	GENE	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	31
PDCD1	GENE	0.268817204301075	25	718.5	0.422314739695225	2.43413277215915	0.640347299108444	0.304235874905531	111
pericarditis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	1
phenotype	MESH	0.021505376344086	2	39	0.303452634543438	3.1897472921677	0.529631140376435	7.46683982429678	76
phosphatidylinositol 3-kinases/metabolism	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	22
phthalazines/administration & dosage	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	33
PIK3CD	GENE	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	162
piperazines/administration & dosage	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	37
piperidines/therapeutic use	MESH	0.021505376344086	2	7.5	0.313108966769043	1.43422320133247	0.227565409941146	-1.43597475616972	134
pneumonia	MESH	0.010752688172043	1	0	0.357857775196501	0.524813794004542	0.0876697162170037	-3.3294077904013	145
pneumonia/chemically induced	MESH	0.032258064516129	3	2751.5	0.382699557931358	3.61421022274165	0.910494726414545	20.5497061678329	58
pneumonia/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	4
poly(adp-ribose) polymerase inhibitors/administration & dosage	MESH	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	36
postoperative complications	MESH	0.010752688172043	1	63.3333333333333	0.389296757576958	0.509429102632434	0.0993531845463551	-10.7173723121302	248
prednisolone/administration & dosage	MESH	0.0104166666666666	1	0	0.348201333855161	1.48155513799669	0.226909853738127	5.89788604221745	82
prednisolone/therapeutic use	MESH	0.010752688172043	1	0	0.383097468844123	0.509429102632434	0.0756366179127091	-9.37795930554749	224
prednisone/therapeutic use	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	2
programmed cell death 1 receptor/antagonists & inhibitors	MESH	0.086021505376344	8	851.5	0.478821308929526	1.88935548083383	0.487063690927102	-9.07632857183322	208
programmed cell death 1 receptor/metabolism	MESH	0.010752688172043	1	0	0.320033043605423	0.84904850438739	0.128926053260299	-2.14629212073704	137
protective agents/pharmacology	MESH	0.010752688172043	1	66.4944444444445	0.308037810226258	0.84904850438739	0.177000174814987	4.59422445269527	98
protein kinase inhibitors/adverse effects	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	160
protein kinase inhibitors/therapeutic use	MESH	0.010752688172043	1	380.833333333333	0.391687023555646	0.84904850438739	0.22288910902628	-8.29023513982519	190
proton pump inhibitors/adverse effects	MESH	0.010752688172043	1	0	0.323616026228441	0.509429102632434	0.0756366179127091	15.9765991949113	60
pruritus/chemically induced	MESH	0.010752688172043	1	75.5641025641028	0.325101278909351	2.91309349943381	0.604204300448692	28.8076842642008	5
psoriasis	MESH	0.010752688172043	1	0	0.35571089629029	1.01885820526487	0.166744362216654	-8.36285698528234	191
purines/adverse effects	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	164
pyrimidines/therapeutic use	MESH	0.021505376344086	2	7.5	0.313108966769043	1.43422320133247	0.223981702697978	-1.43671338285343	135
quinazolinones/adverse effects	MESH	0.0106382978723404	1	0	0.356647111752188	2.53055031630871	0.366149991259251	-5.47628215110788	155
receptors antigen t-cell/genetics	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	114
receptors cxcr3/genetics	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	120
receptors cxcr6/genetics	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	116
recurrence	MESH	0.010752688172043	1	637.714285714286	0.399390350704391	3.9550074870445	0.792421770293106	-3.921490525629	146
rna	MESH	0.010752688172043	1	0	0.35571089629029	1.01885820526487	0.166744362216654	-8.36285698528234	194
sarcoidosis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	3
sirolimus/therapeutic use	MESH	0.010752688172043	1	209	0.296713508547796	1.86790670965226	0.395009032107686	25.525728661401	24
skin neoplasms/complications	MESH	0.010752688172043	1	0	0.295492926557018	0.509429102632434	0.0756366179127091	-0.287950486835561	129
skin neoplasms/drug therapy	MESH	0.021505376344086	2	207.5	0.377259818283361	2.28327170571986	0.508493094807995	-8.17612517288231	188
skin neoplasms/immunology	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	7
SNCA	GENE	0.032258064516129	3	40	0.369529710736748	1.5282873078973	0.295000291358312	-8.2322551437966	189
squamous cell carcinoma of head and neck/drug therapy	MESH	0.010752688172043	1	0	0.386172604275427	1.18866790614235	0.189091544781773	-9.5590888834226	230
steroids/adverse effects	MESH	0.010752688172043	1	0	0.292015372107767	0.339619401754956	0.0446943651302372	-6.02062031580299	174
steroids/therapeutic use	MESH	0.021505376344086	2	33	0.33489825280533	0.509429102632434	0.0935842899597926	4.73746671013551	96
t-lymphocyte subsets/immunology	MESH	0.010752688172043	1	0	0.382953305400168	0.339619401754956	0.0446943651302372	-9.31891744420854	221
t-lymphocytes cytotoxic/immunology	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	51
t-lymphocytes regulatory/cytology	MESH	0.010752688172043	1	0	0.289762188013889	2.03771641052974	0.326612668259425	0.289055971427599	119
TCIM	GENE	0.010752688172043	1	0	0.35571089629029	1.01885820526487	0.166744362216654	-8.36285698528234	192
thyroiditis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	11
TIPARP	GENE	0.010752688172043	1	30	0.243746876208342	2.03771641052974	0.401346075403531	24.243953293794	38
TNF	GENE	0.032258064516129	3	5454	0.499958427840242	3.11611569168628	0.902292989919002	-10.6951407017524	247
tongue neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.386172604275427	1.18866790614235	0.189091544781773	-9.5590888834226	229
trinitrobenzenesulfonic acid/adverse effects	MESH	0.010752688172043	1	66.4944444444445	0.308037810226258	0.84904850438739	0.177000174814987	4.59422445269527	99
tryptophan/pharmacology	MESH	0.010752688172043	1	1606.30952380952	0.423259351911908	0.679238803509912	0.20800069925995	-8.4021511995583	198
tumor microenvironment/drug effects	MESH	0.010752688172043	1	23.7272727272728	0.241229398184178	2.03771641052974	0.373667035720529	21.7380572811767	56
tumor necrosis factor inhibitors	MESH	0.010752688172043	1	0	0.368224137572209	0.84904850438739	0.128926053260299	-7.5896650762598	185
ulcer/chemically induced	MESH	0.010752688172043	1	0	0.383093534304753	0.339619401754956	0.0446943651302372	-9.45914204506677	228
urothelium/drug effects	MESH	0.010752688172043	1	635.5	0.353051185470503	1.18866790614235	0.342928733756774	8.08316227145964	73
ustekinumab/therapeutic use	MESH	0.010752688172043	1	0	0.291937745661787	0.509429102632434	0.0756366179127091	2.79283374408792	102
virus diseases/etiology	MESH	0.010752688172043	1	0	0.384027234545669	0.679238803509912	0.101421828564769	-9.75400787925831	239
vitamin d	MESH	0.010752688172043	1	0	0.39241025381219	0.339619401754956	0.0446943651302372	-8.99204122324688	206
vitamin d/administration & dosage	MESH	0.010752688172043	1	64.6527777777778	0.415351597205809	1.01885820526487	0.224680962647864	-6.38644759644936	181
